Bristol-Myers Squibb

Industry / private company


Location: New York City, United States (USA) (US) US

ISNI: 0000000403748313

ROR: https://ror.org/00gtmwv55

Show on Map:

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Correction to: Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study (Clinical Rheumatology, (2019), 38, 5, (1413-1424), 10.1007/s10067-019-04449-w) (2019) Alten R, Mariette X, Lorenz HM, Nüsslein H, Galeazzi M, Navarro F, Chartier M, et al. Journal article, Erratum Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study (2019) Alten R, Mariette X, Lorenz HM, Nüsslein H, Galeazzi M, Navarro F, Chartier M, et al. Journal article Abatacept retention and clinical outcomes in rheumatoid arthritis: real-world data from the German cohort of the ACTION study and a comparison with other participating countries (2019) Alten R, Feist E, Lorenz HM, Nüsslein H, Voll RE, Chartier M, Elbez Y, Rauch C Journal article Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting (2018) Alten R, Burkhardt H, Feist E, Krüger K, Rech J, Rubbert-Roth A, Voll RE, et al. Journal article A DREAM challenge to build prediction models for short-term discontinuation of docetaxel in metastatic castration- resistant prostate cancer (2017) Seyednasrollah F, Wang T, Piccolo SR, Vega R, Greiner R, Fuchs C, Gofer E, et al. Journal article Baseline Structural Damage Predicts Response to Abatacept in Patients with Psoriatic Arthritis: A Post Hoc Analysis from a Phase III Study (2017) Schett G, Lehman T, Ahmad HA, Johnsen A, Banerjee S, Mease PJ Conference contribution Defective IL-23/IL-17 Axis Protects p47phox-/- Mice from Colon Cancer (2017) Richter C, Juan MHS, Weigmann B, Bergis D, Dauber K, Muders MH, Baretton GB, et al. Journal article Loss of Function of GALNT2 Lowers High-Density Lipoproteins in Humans, Nonhuman Primates, and Rodents (2016) Khetarpal SA, Schjoldager KT, Christoffersen C, Raghavan A, Edmondson AC, Reutter HM, Ahmed B, et al. Journal article Implementation of amplicon parallel sequencing leads to improvement of diagnosis and therapy of lung cancer patients (2015) Koenig K, Peifer M, Fassunke J, Ihle MA, Kuenstlinger H, Heydt C, Stamm K, et al. Journal article
‹ 1 2 ›